1. 339 Clinical outcome and prognostic factors of patients (pts) with relapsed mesothelioma on phase I trials in the Drug Development Unit (DDU) of the Royal Marsden Hospital (RMH). (September 2015) Authors: Papadatos-Pastos, D.; Roda, D.; Luken, M. De Miguel; Jalil, A.; Diamantis, N.; Michalarea, V.; Lima, J.; Capelan, M.; Bodla, S.; Bhosle, J.; Molife, R.; O'Brien, M.; Banerji, U.; Popat, S.; Yap, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Febrile Neutropenia Rates According to BMI and Dose-capping: a Retrospective Analysis in a Tertiary Referral Centre. Issue 5 (May 2016) Authors: Lote, H.; Sharp, A.; Redana, S.; Papadimitraki, E.; Capelan, M.; Ring, A. Journal: Clinical oncology Issue: Volume 28:Issue 5(2016) Page Start: e5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Febrile Neutropenia Rates According to Body Mass Index and Dose Capping in Women Receiving Chemotherapy for Early Breast Cancer. Issue 9 (September 2016) Authors: Lote, H.; Sharp, A.; Redana, S.; Papadimitraki, E.; Capelan, M.; Ring, A. Journal: Clinical oncology Issue: Volume 28:Issue 9(2016) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pathologic Response Rates Following Neoadjuvant Anthracycline and Taxane-based Chemotherapy for Early Breast Cancer (EBC). Issue 6 (June 2017) Authors: Redana, S.; Papadimitraki, E.; Mohammed, K.; Lote, H.; Sharp, A.; Capelan, M. Journal: Clinical oncology Issue: Volume 29:Issue 6(2017) Page Start: e103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Rates of major complications during neoadjuvant and adjuvant chemotherapy for early breast cancer: An off study population. (December 2016) Authors: Redana, S.; Sharp, A.; Lote, H.; Mohammed, K.; Papadimitraki, E.; Capelan, M.; Ring, A. Journal: Breast Issue: Volume 30(2016) Page Start: 13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Rates of Venous Thromboembolism (VTE) and Other Major Complications During Peri-operative Chemotherapy (CT) for Early Breast Cancer (EBC) in an Off-study Population. Issue 5 (May 2016) Authors: Redana, S.; Sharp, A.; Papadimitraki, E.; Lote, H.; Capelan, M.; Ring, A. Journal: Clinical oncology Issue: Volume 28:Issue 5(2016) Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Treatment with eribulin in HER2-negative breast cancer patients with brain metastases: Experience at Vall d' Hebron University Hospital. (April 2018) Authors: Garrigós, L.; Ortiz, C.; Ruiz-Pace, F.; Arumi, M.; Bellet, M.; Capelan, M.; Escrivá, S.I.; Gomez, P.; Muñoz, E.; Oliveira, M.; Rojas, B.; Zamora, E.; Dienstmann, R.; Saura, C. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗